- Implications for Patient Care: Our data shed light on the application of tumor LS in predicting HCC progression, which might guide the development of rational strategies for use of anti-PD-1 in combination antiangiogenic agents, ultimately benefiting a broader range of patients. Here, PDCD1 is linked to hepatocellular carcinoma.